You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial

 

Online download statistics by month:

Online download statistics by month: October 2020 to July 2025

AbstractFullPdf
Oct 2020385385241
Nov 2020343344184
Dec 202030630673
Jan 2021250250117
Feb 202119719789
Mar 2021213213101
Apr 2021228228100
May 202121921985
Jun 202119619681
Jul 202116216274
Aug 202115615661
Sep 202114314269
Oct 2021205205120
Nov 2021200200122
Dec 202116316489
Jan 202220822888
Feb 202216116995
Mar 2022253278155
Apr 2022202210121
May 2022228244109
Jun 202218118471
Jul 202220320573
Aug 202218018692
Sep 202215016081
Oct 202224224497
Nov 202218418494
Dec 202213213265
Jan 202323723951
Feb 202317617878
Mar 202313813889
Apr 202312813163
May 202319119885
Jun 202315616278
Jul 202314714979
Aug 202313213262
Sep 202312812963
Oct 202312412477
Nov 202313013069
Dec 202312412487
Jan 202411612292
Feb 202413513770
Mar 2024152153152
Apr 202416416599
May 2024140140119
Jun 202413313392
Jul 202413613882
Aug 2024128128113
Sep 2024180181115
Oct 2024175176104
Nov 202419519689
Dec 202419719999
Jan 202516416491
Feb 2025277277147
Mar 2025227227146
Apr 2025245248160
May 202518218498
Jun 2025848658
Jul 2025110
Total10532106805554